CVS Health
CVS
1,844 hedge funds and large institutions have $84B invested in CVS Health in 2025 Q3 according to their latest regulatory filings, with 214 funds opening new positions, 672 increasing their positions, 725 reducing their positions, and 108 closing their positions.
98% more first-time investments, than exits
New positions opened: 214 | Existing positions closed: 108
45% more capital inflows, than outflows
Capital inflows: $4.33B | Capital outflows: $2.99B
21% more call options, than puts
Call options by funds: $2.26B | Put options by funds: $1.88B
5% more funds holding
Funds holding: 1,764 → 1,844 (+80)
1.17% more ownership
Funds ownership: 86.71% → 87.87% (+1.2%)
7% less repeat investments, than reductions
Existing positions increased: 672 | Existing positions reduced: 725
3% less funds holding in top 10
Funds holding in top 10: 34 → 33 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$576M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$346M |
| 3 |
Amundi
Paris,
France
|
+$249M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$154M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$150M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$340M |
| 2 |
Jennison Associates
New York
|
-$207M |
| 3 |
BlackRock
New York
|
-$195M |
| 4 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
-$183M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$156M |
CVS Hedge Fund Activity: Q3 2025 in Review
1,844 of the 7,660 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q3 2025, worth a combined $84B — up 11% from $75.6B a quarter earlier.
Buyers outnumbered sellers: 214 funds opened new CVS positions and 108 closed out — a net gain of 106 holders — while 672 added to existing stakes and 725 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $576M. The largest seller was Citadel Advisors, cutting an estimated $340M.
- 1,844 institutional investors held CVS Health (CVS) as of Q3 2025, up from 1,764 in Q2 2025.
- Funds reported $84B of CVS Health stock for Q3 2025, up 11% quarter-over-quarter.
- 214 funds opened new CVS Health positions in Q3 2025 and 108 closed out, a net change of +106 holders.
- The largest CVS Health buyer in Q3 2025 was JP Morgan Chase, an estimated $576M added.
- The largest CVS Health seller in Q3 2025 was Citadel Advisors, an estimated $340M sold.
Based on aggregated 13F filings for Q3 2025.